approval
saveTRUQAP (CAPIVASERTIB) — FDA approval
community read0 votes
Sponsor: ASTRAZENECA. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 4
- fda advisory committee meetingAstraZeneca Plc — capivasertib (FDA Advisory Committee Meeting)Apr 30, 2026 · 157d ago
- approvalTRUQAP (CAPIVASERTIB) — FDA approvalFeb 13, 2025 · 598d ago
- approvalTRUQAP (CAPIVASERTIB) — FDA approvalSep 23, 2024 · 741d ago
- approvalTRUQAP (CAPIVASERTIB) — FDA approvalNov 16, 2023 · 1053d ago
same company · ±60 days · 6
- approvalselumetinib sulfate: KOSELUGO (SELUMETINIB SULFATE) — FDA approvalNov 19, 2025
- approvalselumetinib sulfate: KOSELUGO (SELUMETINIB) — FDA approvalNov 19, 2025
- approvalIMFINZI (DURVALUMAB) — FDA approvalNov 25, 2025
- recallASTRAZENECA PHARMACEUTICALS recall (Cls II)Oct 22, 2025
- approvalnirsevimab: BEYFORTUS (NIRSEVIMAB-ALIP) — FDA approvalOct 20, 2025
- approvaltezepelumab: TEZSPIRE (TEZEPELUMAB-EKKO) — FDA approvalOct 17, 2025
comments(0)
5-min edit window · permanent after that